Alithea Genomics, a pioneering biotech company specializing in scalable RNA sequencing solutions, today announced a new agreement with Revvity Inc. to broaden access to MERCURIUS™ DRUG-seq and MERCURIUS™ Total DRUG-seq solutions through Revvity’s global commercial network.  The collaboration brings together Alithea Genomics’ scalable high-throughput transcriptomics technologies with Revvity’s comprehensive drug discovery and screening portfolio, enabling […]

Company plans to showcase new volumetric MERFISH datasets in mouse brain and human neurodegenerative brain tissue, generated on the existing MERSCOPE Ultra™ Platform WALTHAM, Mass. — Vizgen, Inc., a leader in spatial multiomics and developer of the MERSCOPE Ultra™ Platform, today announced it will debut a 3D Volumetric Tissue Mapping dataset in neurodegenerative brain tissue […]

StrataMap Spatial gives researchers access to spatial biology at true single cell resolution for discovery without boundaries Whole-transcriptome profiling across a large tissue capture area can generate 2x more unique genes per sample than probe-based technologies SAN DIEGO — Illumina, Inc. (NASDAQ: ILMN) today announced the launch of the StrataMap Spatial Solution, offering an unmatched breadth […]

MilliporeSigma appoints Clara Sattler de Sousa e Brito and Robert Machinek to strengthen leadership team. Clara Sattler de Sousa e Brito appointed Head of Discovery Solutions, bringing extensive international leadership experience across healthcare, medtech and the chemical industry Robert Machinek appointed Head of Strategy & Business Development, bringing deep expertise in life science strategy, M&A […]

Combined company to operate as Treeline Biosciences, advancing a deep pipeline of small molecule inhibitors, protein degraders and targeted therapy antibody-drug conjugates Company to be led by Treeline CEO and co-founder Josh Bilenker, MD, and experienced team of proven drug developers Treeline’s pipeline includes three Phase 1 programs with multiple anticipated clinical data readouts beginning in 2027 Well capitalized with over $900 million in cash expected […]

SOPHiA GENETICS and Memorial Sloan Kettering Cancer Center Aim to Establish Precision Medicine Hub for the Next Generation of Precision Oncology NEW YORK — SOPHiA GENETICS (NASDAQ: SOPH) today announced that the company has signed a Memorandum of Understanding (MOU) with Memorial Sloan Kettering Cancer Center (MSK) relating to the formation of a joint venture between the two […]

New integrated workflow combines icIEF fractionation and mass photometry Enables direct characterization of aggregation and size within icIEF-resolved charge variants Four-hour workflow reduces development risk and accelerates biosimilar manufacturing MINNEAPOLIS and OXFORD, England — Bio‑Techne Corporation (NASDAQ: TECH), a global provider of life science tools, reagents and diagnostic products, and Refeyn, the pioneer in mass photometry technology, […]

Strategic partnership integrates Pluristyx’s clinical-grade iPSC platform into Made Scientific’s CDMO services, giving developers a single-source path from cell line to commercial supply. PRINCETON, N.J. and SEATTLE — Made Scientific, Inc., a leading U.S.-based clinical- and commercial-stage cell therapy contract development and manufacturing organization (CDMO), and Pluristyx, a leading provider of RUO and GMP induced […]

North Brunswick, NJ – Distek, Inc., a leading manufacturer of bioprocessing equipment, announces the release of their BIOne Core Software, an advanced, cloud-based historian software platform designed exclusively for BIOne Bioprocess Controllers. Delivered as a Software-as-a-Service (SaaS) solution, BIOne Core enables users to easily visualize, monitor, and manage critical bioprocess data while minimizing on-premise IT infrastructure. Designed […]

VALHALLA, N.Y. — FUJIFILM Holdings America Corporation today announces additional leadership responsibilities for three key leaders in its Life Sciences Group companies. Tomoyuki Hasegawa will now serve as CEO of FUJIFILM Biotechnologies California, a global CDMO for biologics and advanced therapies. He will also continue to serve as General Manager of Fujifilm Life Sciences Strategic […]